Answers are grounded in this paper and cite their sources.
This analysis reveals biomarker-responsive prodrug release in lung cancer cells, suggesting improved treatment options.
A versatile method for tertiary amine-based prodrugs enables signal-triggered activation and polymer conjugation, allowing controlled, biomarker-responsive release from prodrug-labelled hydrogels with inhibited lung cancer cell migration in vitro .
No takes yet. Share an insight, caveat, or question.
Klemm et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: